Literature DB >> 10677250

Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.

N Ganne-Carrie1, A Medini, E Coderc, O Seror, C Christidis, S Grimbert, J C Trinchet, M Beaugrand.   

Abstract

In order to establish a relationship between Hepatitis C virus (HCV) chronic infection and autoimmune thyroiditis, 97 untreated patients with biopsy-proven HCV chronic hepatitis and 97 controls were studied. An ultrasound examination of the thyroid and an assay of serum thyroid-stimulating hormone (TSH), thyroid hormones and anti-thyroid antibodies were performed in all cases. The overall prevalence of thyroid abnormalities was higher in patients than in controls (17 vs. 4%, P<0.01) and the prevalence of anti-thyroid antibodies was significantly different between the two groups (P<0. 02). HCV patients with (n=13) compared to HCV patients without anti-thyroid antibodies (n=84) were older, predominantly female, and more frequently had increased serum TSH levels or a hypoechogenic pattern of the thyroid gland, while Knodell's score and prevalence of cirrhosis were similar. Latent autoimmune thyroiditis is more frequent in untreated HCV patients than in controls. This finding raises questions about the mechanism of autoimmunity induced by HCV and provides an explanation for the high rate of overt autoimmune thyroiditis during interferon treatment in these patients. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677250     DOI: 10.1006/jaut.1999.0360

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  24 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

2.  HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity.

Authors:  Nagako Akeno; Jason T Blackard; Yaron Tomer
Journal:  J Autoimmun       Date:  2008-09-16       Impact factor: 7.094

Review 3.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

4.  Interferon graft dysfunction: a final chapter for interferon and hepatitis C.

Authors:  Julie A Thompson; John R Lake
Journal:  Hepatol Int       Date:  2014-04-06       Impact factor: 6.047

Review 5.  Cutting edge: the etiology of autoimmune thyroid diseases.

Authors:  Deirdre Cocks Eschler; Alia Hasham; Yaron Tomer
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 6.  Environmental triggers of thyroiditis: hepatitis C and interferon-α.

Authors:  F Menconi; A Hasham; Y Tomer
Journal:  J Endocrinol Invest       Date:  2010-02-28       Impact factor: 4.256

Review 7.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 8.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

9.  Gastric autoimmune disorders in patients with chronic hepatitis C before, during and after interferon-alpha therapy.

Authors:  Carlo Fabbri; M Francesca Jaboli; Silvia Giovanelli; Francesco Azzaroli; Alessandro Pezzoli; Esterita Accogli; Stefania Liva; Giovanni Nigro; Anna Miracolo; Davide Festi; Antonio Colecchia; Marco Montagnani; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Detection of anti-HAV antibody with dot immunogold filtration assay.

Authors:  Zhong-Jun Shao; De-Zhong Xu; Yong-Ping Yan; Jing-Hua Li; Jing-Xia Zhang; Zhi-Ying Zhang; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.